SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001047469-14-008918
Filing Date
2014-11-06
Accepted
2014-11-06 16:14:31
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 a2222060z424b5.htm 424B5 218640
2 G148431.JPG g148431.jpg GRAPHIC 16723
  Complete submission text file 0001047469-14-008918.txt   243017
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-192640 | Film No.: 141200845
SIC: 2835 In Vitro & In Vivo Diagnostic Substances